Humanoid robots are getting the headlines. The money, for now, is still mostly in warehouse automation, cobots and industrial systems. Symbotic and Teradyne already report measurable robotics revenue from deployed products. Hyundai has commercial robots today and a funded route toward Atlas deployment. Rockwell Automation sells the factory-control layer around robotics. Tesla is the outlier: Optimus could become a huge business, but right now it is still a pre-commercial manufacturing program rather than a meaningful revenue stream.
Humanoid robots can now run, manipulate objects and perform increasingly complex demonstrations. That is enough to excite investors, but not enough to prove a business model. Reuters reported in late August that even China’s heavily funded humanoid industry still struggles to turn impressive hardware into reliable factory work. I would separate the stocks here into two camps: companies already getting paid for automation, and companies whose humanoid value still depends heavily on what they may build later.
Why Humanoid Robots Are Suddenly an Investable Theme
The robotics story changed when large AI models began moving from screens into physical systems. Better perception, simulation and foundation models can help machines adapt to less structured environments. At the same time, labor shortages and reshoring make factory automation easier to justify economically.
Physical AI is not starting from zero. Warehouses already use autonomous mobile systems. Factories already deploy collaborative robot arms. Industrial software already coordinates motion, safety and production. That matters because the first real winners may not look like science fiction. They may look like better warehouse economics, easier robot programming and more automated production lines.
The Robotics Market Has Four Different Layers
Systems already generating revenue
Automated storage, retrieval and movement systems can produce immediate labor and throughput savings in controlled environments.
Flexible industrial arms
Cobots work alongside employees and are easier to deploy than traditional fenced industrial robots for many tasks.
Automation infrastructure
Robots still depend on controls, sensors, safety systems, software and manufacturing execution infrastructure.
Largest future optionality
General-purpose robots could address more tasks, but reliability, dexterity, cost and production scale remain major hurdles.
Which robotics stocks have the strongest evidence today?
Both report measurable robotics sales from systems already being deployed with commercial customers.
Rockwell owns the industrial automation layer. Hyundai combines existing Boston Dynamics products with a funded Atlas commercialization path.
Optimus production lines are being installed, but the first builds are intended mainly for training and development rather than external commercial revenue.
5 Listed Companies With Different Types of Robotics Exposure
| Company | What is measurable today | Robotics exposure | Main risk |
|---|---|---|---|
| Symbotic | Q3 FY26 revenue $721M; 77 systems in deployment; net income $55M | AI-enabled warehouse robotics and software | Customer concentration and large-project execution |
| Teradyne | Q2 robotics revenue $99.9M, up from $74.9M a year earlier | Universal Robots cobots and MiR mobile robots | Robotics remains much smaller than semiconductor test |
| Rockwell | Q3 reported sales +8%; FY26 sales midpoint about $9.0B | Factory controls, software, motion and industrial automation | Robotics is embedded in a broad automation portfolio, not separately reported |
| Hyundai Motor | Boston Dynamics already sells Spot and Stretch; Atlas factory deployment targeted from 2028 | Existing commercial robots plus humanoid production ecosystem | Robotics remains immaterial to Hyundai’s automotive financials today |
| Tesla | Optimus production lines being installed; initial builds intended for training data collection | Potential vertically integrated humanoid platform | No material external Optimus revenue yet; execution and valuation risk |
1. Symbotic: The Strongest Pure Robotics Revenue Evidence
Symbotic is the cleanest example in this group of robotics already translating into material financial results. In fiscal Q3 2026, revenue reached $721 million, up 22% year over year. Net income was $55 million and adjusted EBITDA reached $95 million. The company said 77 systems were in deployment.
Symbotic is not a humanoid story, and that is partly why I like it as a benchmark. This is what robotics commercialization looks like when the economics stop being theoretical: customers pay for a specific workflow, deployments scale, and revenue shows up as systems are installed and operated.
2. Teradyne: Collaborative Robots Already Produce Segment Revenue
Teradyne owns Universal Robots and Mobile Industrial Robots, giving it direct exposure to collaborative arms and autonomous mobile robots. Its Q2 2026 filing reported $99.9 million of robotics revenue, up from $74.9 million a year earlier. For the first half of 2026, robotics revenue reached $191.2 million, up 32.9% year over year.
The catch is simple: semiconductor test is still the much larger business. The robotics segment is real and growing, but TER is not a clean robotics pure play. That dilution matters when the theme is what attracts you to the stock in the first place.
3. Rockwell Automation: The Picks-and-Shovels Layer of Factory Robotics
Rockwell Automation is less exciting than a humanoid demo, but I would not dismiss that as a weakness. Modern robots need controllers, drives, safety systems, factory software, motion control and integration with production lines. Rockwell sells into that less glamorous layer where automation budgets already exist.
In fiscal Q3 2026, reported sales increased 8% year over year and organic sales rose 10%. The company raised its fiscal-year sales outlook to a midpoint of roughly $9.0 billion. The limitation is visibility: robotics is not separately disclosed, so this is broad industrial-automation exposure rather than a pure robotics revenue stream.
4. Hyundai Motor: Boston Dynamics Gives It the Most Credible Humanoid Manufacturing Path
Hyundai’s robotics exposure is more interesting than the ticker suggests. Boston Dynamics already has commercial products, while Atlas remains a future industrial-humanoid program. Hyundai says Spot and Stretch are being built today and that Atlas is moving toward mass production. At its 2026 CEO Investor Day, the company said Atlas deployment at Hyundai Motor Group Metaplant America is targeted from 2028.
Hyundai has also described a production system capable of manufacturing 30,000 robots annually by 2028. I would not treat that capacity target as demand. Still, the combination of an existing robotics subsidiary, manufacturing infrastructure, internal deployment sites and a distribution and financing network gives Hyundai a more credible route to commercialization than a standalone prototype story.
5. Tesla: The Biggest Humanoid Narrative Still Has the Least Current Robotics Revenue
Tesla may have the largest public-market humanoid narrative. Its July 2026 filing said Model S and X manufacturing lines at Fremont had been decommissioned and first-generation Optimus production lines were being installed. Tesla also said the initial builds would be used in its Optimus Academy for training-data collection and functionality development.
That is a meaningful milestone, but it is not the same thing as a commercial robotics business. Optimus could eventually become enormous. Today, Tesla’s financials are still dominated by vehicles, energy and related services. Anyone buying the humanoid thesis is paying for a lot of future execution before there is material external Optimus revenue to point to.
What the Robotics Narrative Gets Right
- Automation spending is already producing meaningful revenue for listed companies.
- AI models can expand the number of tasks robots can perform outside rigidly programmed workflows.
- Labor shortages and manufacturing reshoring create real economic incentives for automation.
- Hyundai and Tesla are committing physical manufacturing capacity to humanoid programs.
- Existing warehouse and collaborative robots provide a commercialization bridge while humanoids mature.
What the Narrative Can Overstate
- A demonstration is not a deployment. Robots can perform impressive scripted tasks without being reliable enough for continuous factory use.
- Production capacity is not demand. A target for tens of thousands of robots matters only if customers can justify the economics.
- Humanoid form is not always optimal. Conventional arms, mobile robots and purpose-built systems often perform specific industrial tasks more cheaply.
- Robotics exposure can be diluted. Tesla, Hyundai, Teradyne and Rockwell all have larger businesses outside robotics.
- Valuations can front-run commercialization. Investors may price decades of potential before unit economics and repeat customers are proven.
Humanoid robotics is a real investment theme, but the strongest evidence in public markets is still coming from companies that sell automation today. Symbotic is the clearest pure robotics revenue story in this group. Teradyne has a genuine collaborative-robotics business. Rockwell gets paid for the factory infrastructure around robot deployments. Hyundai is the most interesting bridge between commercial robots and a funded humanoid manufacturing plan.
Tesla is different. Optimus may ultimately have the biggest upside, but it also asks investors to underwrite the most future economics. I would not put these five names in one neat “humanoid robot stocks” basket. The gap between a robot demo and a repeatable commercial deployment is still the part of this story that matters most.
Sources
Investment disclosure: This article is for informational and research purposes only. It is not investment advice, a recommendation to buy or sell securities, or a price target.